Login/Sign Up
₹1589
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Salmocalcitone Nasal Solution 30 MDI is primarily indicated for the treatment of postmenopausal osteoporosis in women more than five years postmenopause when alternative therapies are unsuitable. Post-menopausal osteoporosis is a medical condition that causes thinning and weakening of the bones during/after a menopausal period.
Salmocalcitone Nasal Solution 30 MDI contains Calcitonin, a human hormone that prevents bone breakdown and increases bone density (thickness). Thus, it helps treat osteoporosis in postmenopausal women.
Use Salmocalcitone Nasal Solution 30 MDI as prescribed by the doctor. Salmocalcitone Nasal Solution 30 MDI may cause certain side effects such as hypocalcemia, runny nose, nosebleed, sinus pain, application site reactions such as rhinitis (stuffy nose), epistaxis (nose bleeds) and other nasal symptoms, back pain, arthralgia (Joint pain) and headache. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.
Salmocalcitone Nasal Solution 30 MDI is for intranasal use only; do not inject or take it orally. Before using Salmocalcitone Nasal Solution 30 MDI, inform your doctor of all your medical conditions, sensitivities, and medications. Salmocalcitone Nasal Solution 30 MDI is intended for post-menopausal women; therefore, it should not be recommended for other populations. Avoid drinking alcohol because it affects how the body absorbs calcium and vitamin D, which are essential for good bone formation.
Salmocalcitone Nasal Solution 30 MDI is used in the treatment of Postmenopausal osteoporosis. The detailed uses of Salmocalcitone Nasal Solution 30 MDI are as follows:
Salmocalcitone Nasal Solution 30 MDI contains Calcitonin, a calcitonin receptor agonist that prevents the loss of bones that happens after menopause and helps to rebuild bones. Calcitonin is a hormone that the C-cells in the thyroid gland produce and release. It opposes the parathyroid hormone's action, helping regulate the blood’s calcium and phosphate levels. Salmocalcitone Nasal Solution 30 MDI works by suppressing the activity of the osteoclasts (cells that break down bone). When the osteoclasts break down bone tissue, the calcium enters the bloodstream. Salmocalcitone Nasal Solution 30 MDI lessens the amount of calcium in the blood by preventing the breakdown of bone. Thereby, Salmocalcitone Nasal Solution 30 MDI strengthens the bones and minimizes the risk of fractures. Salmocalcitone Nasal Solution 30 MDI also seems to decrease the amount of calcium the kidneys can re-absorb, lowering calcium levels further.
Caution
Consuming alcohol is not advisable; it affects how the body absorbs calcium and vitamin D, both of which are essential for good bone formation.
Not applicable
Salmocalcitone Nasal Solution 30 MDI is intended for postmenopausal women only. So, it is not recommended for use in pregnancy.
Not applicable
Salmocalcitone Nasal Solution 30 MDI is intended for postmenopausal women only. So, it is not recommended for use in breastfeeding women.
Safe
Salmocalcitone Nasal Solution 30 MDI does not impact your ability to drive or operate machinery.
Caution
Limited information is available on the use of Salmocalcitone Nasal Solution 30 MDI in patients with liver disease. Inform your doctor before receiving the Salmocalcitone Nasal Solution 30 MDI if you have a history of liver impairment. Your doctor will prescribe only if the benefits outweigh the risks.
Caution
Limited information is available about using Salmocalcitone Nasal Solution 30 MDI in patients with liver disease. Inform your doctor before receiving the Salmocalcitone Nasal Solution 30 MDI if you have a history of liver impairment. Your doctor will prescribe only if the benefits outweigh the risks.
Not applicable
Salmocalcitone Nasal Solution 30 MDI is intended for postmenopausal women only. So, it is recommended not to use it in children.
Caution
Salmocalcitone Nasal Solution 30 MDI should be used with caution in patients with heart disease. Please consult the doctor if you have heart problems.
Consult your doctor
Please consult a doctor before administering Salmocalcitone Nasal Solution 30 MDI to geriatric patients. Your doctor will prescribe Salmocalcitone Nasal Solution 30 MDI if the benefits outweigh the risks.
Have a query?
Before using Salmocalcitone Nasal Solution 30 MDI, Inform your doctor about all your medical conditions, sensitivities, and all medications you are using. Salmocalcitone Nasal Solution 30 MDI is intended for post-menopausal women; therefore, Salmocalcitone Nasal Solution 30 MDI should not be recommended for other populations. In rare situations, individuals using Salmocalcitone Nasal Solution 30 MDI may be affected with anaphylactic shock (a sudden, severe, life-threatening allergic reaction leading to difficulty breathing); if you encounter it, stop using Salmocalcitone Nasal Solution 30 MDI and contact your doctor immediately.
Drug-Drug interactions: Salmocalcitone Nasal Solution 30 MDI may interact with certain medicines used to treat mood disorders (e.g. lithium), medicines used to treat secondary hyperparathyroidism (e.g. etelcalcetide) and antiviral medications (e.g. foscarnet).
Drug-Food interactions: No interactions found.
Drug-Disease interactions: Salmocalcitone Nasal Solution 30 MDI interacts with disease conditions, including hypocalcaemia (low calcium level) and mineral metabolism disorder.
Login/Sign Up
Login/Sign Up
Pharmanova Specialties Pvt Ltd
₹2030.5
(₹33.84/ 1MDI)
Xenone Healthcare Pvt Ltd
₹2118.5
(₹35.31/ 1MDI)
Isakura Healthcare
₹2498
(₹41.63/ 1MDI)
Disclaimer

RX
RX